Concepedia

Baxter Hepburn Kachingwe

BH

Statistics

Publications

3

Citations

92

H-Index

3

Active since

2013

Affiliations

Taipei Medical University(Current)

Taipei Medical University Hospital

Baxter Hepburn Kachingwe is an author at Taipei Medical University specializing in pharmacology, cancer risk assessment, and cancer risk.

ORCID

Publications per year

2013–2017

3

Publications

3

Dose effect of thiazolidinedione on cancer risk in type 2 diabetes mellitus patients: a six-year population-based cohort study

Hsiu‐Chen Lin, Yung-Ho Hsu, Baxter Hepburn Kachingwe et al. · Journal of Clinical Pharmacy and Therapeutics · 2014 · 41 citations

, , +14

Effects of Metformin Dose on Cancer Risk Reduction in Patients with Type 2 Diabetes Mellitus: A 6‐Year Follow‐up Study

Hsiu‐Chen Lin, Baxter Hepburn Kachingwe, Hsiu‐Li Lin et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2013 · 38 citations

, , +11

Development and validation of an LC–MS/MS method for quantification of NC-8 in rat plasma and its application to pharmacokinetic studies

Baxter Hepburn Kachingwe, Yow‐Shieng Uang, Tsurng‐Juhn Huang et al. · Journal of Food and Drug Analysis · 2017 · 13 citations · Full text

, , +13

1–3 of 3